Literature DB >> 2987826

Nucleotide sequence of mouse IL-2 receptor cDNA and its comparison with the human IL-2 receptor sequence.

A Shimuzu, S Kondo, S Takeda, J Yodoi, N Ishida, H Sabe, H Osawa, T Diamantstein, T Nikaido, T Honjo.   

Abstract

We have cloned cDNA encoding the mouse interleukin-2 (IL-2) receptor from a murine T cell line, CTLL using human IL-2 receptor cDNA as probe. COS 7 cells transfected with the cDNA expressed the antigen recognized by the monoclonal antibody against the murine IL-2 receptor. The cDNA identified 4 species of mRNA (4.5, 3.5, 2.2 and 1.5 kb) of the mouse IL-2 receptor in CTLL cells. Difference in the length of mRNA seems to be ascribed to the variable length of the 3' untranslated sequence. Total nucleotide sequence (approximately 1400 bp) of this cDNA was determined and compared with the human receptor. The nucleotide and amino acid sequences of the IL-2 receptor are 70% and 60%, respectively, homologous in average between the two species. The comparison has revealed several conserved regions localized to particular exons such as transmembrane and cytoplasmic portions, suggesting that these regions are important for receptor function and its regulation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2987826      PMCID: PMC341092          DOI: 10.1093/nar/13.5.1505

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  30 in total

1.  Cloning and complete nucleotide sequence of mouse immunoglobulin gamma 1 chain gene.

Authors:  T Honjo; M Obata; Y Yamawaki-Katoaka; T Kataoka; T Kawakami; N Takahashi; Y Mano
Journal:  Cell       Date:  1979-10       Impact factor: 41.582

2.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

3.  Selective in vitro growth of T lymphocytes from normal human bone marrows.

Authors:  D A Morgan; F W Ruscetti; R Gallo
Journal:  Science       Date:  1976-09-10       Impact factor: 47.728

4.  Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.

Authors:  P S Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

5.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

6.  Nucleotide sequences of gene segments encoding membrane domains of immunoglobulin gamma chains.

Authors:  Y Yamawaki-Kataoka; S Nakai; T Miyata; T Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  1982-04       Impact factor: 11.205

7.  Plasmid screening at high colony density.

Authors:  D Hanahan; M Meselson
Journal:  Gene       Date:  1980-06       Impact factor: 3.688

8.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

9.  Surface phenotype of Japanese adult T-cell leukemia cells characterized by monoclonal antibodies.

Authors:  T Hattori; T Uchiyama; T Toibana; K Takatsuki; H Uchino
Journal:  Blood       Date:  1981-09       Impact factor: 22.113

10.  T cell growth factor receptors. Quantitation, specificity, and biological relevance.

Authors:  R J Robb; A Munck; K A Smith
Journal:  J Exp Med       Date:  1981-11-01       Impact factor: 14.307

View more
  21 in total

1.  Human and murine IL2 receptors differentially respond to the human-IL2 component of immunocytokines.

Authors:  Zulmarie Perez Horta; Swetha Saseedhar; Alexander L Rakhmilevich; Lakeesha Carmichael; Jacquelyn A Hank; Margaret Boyden; Stephen D Gillies; Paul M Sondel
Journal:  Oncoimmunology       Date:  2018-05-07       Impact factor: 8.110

2.  Molecular basis for two different affinity states of the interleukin 2 receptor: affinity conversion model.

Authors:  S Kondo; A Shimizu; Y Saito; M Kinoshita; T Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

3.  Intracytoplasmic phosphorylation sites of Tac antigen (p55) are not essential for the conformation, function, and regulation of the human interleukin 2 receptor.

Authors:  M Hatakeyama; S Minamoto; T Taniguchi
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

4.  Molecular cloning and structure of the human interleukin 2 receptor gene.

Authors:  N Ishida; H Kanamori; T Noma; T Nikaido; H Sabe; N Suzuki; A Shimizu; T Honjo
Journal:  Nucleic Acids Res       Date:  1985-11-11       Impact factor: 16.971

5.  Cyclosporin A prevents induction of the interleukin 2 receptor gene in cultured murine thymocytes.

Authors:  J F Gauchat; E W Khandjian; R Weil
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

6.  The 5' coding sequence of IL-2 receptor alpha chain mRNA mediates mRNA stabilization by HTLV-1 Rex.

Authors:  H Kanamori; T Kodama; Y Yazaki
Journal:  Immunology       Date:  1995-12       Impact factor: 7.397

7.  Abelson virus transformation of an interleukin 2-dependent antigen-specific T-cell line.

Authors:  W D Cook; B Fazekas de St Groth; J F Miller; H R MacDonald; R Gabathuler
Journal:  Mol Cell Biol       Date:  1987-07       Impact factor: 4.272

8.  Interleukin-2 and interleukin-2 receptor expression in human corticotrophic adenoma and murine pituitary cell cultures.

Authors:  E Arzt; G Stelzer; U Renner; M Lange; O A Müller; G K Stalla
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

9.  Tumour-bearing animals synthesize a decreased level of mRNA for the inducible 55,000 MW interleukin-2 receptor.

Authors:  V Holán; M Lipoldová
Journal:  Immunology       Date:  1990-04       Impact factor: 7.397

10.  Molecular cloning and expression of chicken C-terminal Src kinase: lack of stable association with c-Src protein.

Authors:  H Sabe; B Knudsen; M Okada; S Nada; H Nakagawa; H Hanafusa
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.